Management of genital herpes

Advances in Experimental Medicine and Biology

Volumn 394, Issue , 1996, Pages 1-10

  Mertz, Gregory J ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ALPHA2 INTERFERON; FAMCICLOVIR; FOSCARNET; NONOXINOL 9; VALACICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CONFERENCE PAPER; DRUG COST; DRUG EFFICACY; GENITAL HERPES; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

HERPES;

EID: 0029866497     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9209-6_1     Document Type: Conference Paper

References (33)

1. Reeves C, Corey L, Adams HG, et al. Risk of recurrence after first episodes of genital herpes: Relation to HSV type and antibody response. N Engl J Med 1981;305:315-317.
2. Kost RG, Hill EL, Tigges M, and Straus SE. Recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med 1993;329:1777-82.
3. Mertz GJ, Jones CC, Mills J, et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection: A multicenter double-blind trial. JAMA 1988;260:201-206.
4. Erlich KS, Mills J, Chatis P, et al. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989;320:293-296.
5. Ashley R, Cent A, Maggs A, et al. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus type 1 and 2. Aim Intern Med 1991;115:520-526.
6. Bernstein DI, Lovett MA, and Bryson YJ. Serologic analysis of first-episode nonprimary genital herpes simplex virus infection: presence of type 2 antibody in acute serum samples. Am J Med 1984;77:1055-1060.
7. Corey L, Benedetti J, Critchlow C, et al. Treatment of primary first episode genital HSV infections with acyclovir: Results of topical, intravenous and oral therapy. J Antimicrob Chemother 1983;12:79-88.
8. Mertz GJ, Critchlow CW, Benedetti J, et al. Double-blind placebo-controlled trial of oral acyclovir in first episode genital herpes simplex virus infection. JAMA 1984;252:1147-1151.
9. Drugs for non-HIV viral infections. The Medical Letter 1994;36:27-32.
10. Wald A, Benedetti J, Davis G, et al. A randomized double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections. Antimicrobial Agents & Chemotherapy 1994;38(2):174-6.
11. Reichman RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir: A controlled trial. JAMA 1984;251:2103-2107.
12. The International Valaciclovir HSV Study Group, Smiley ML, Burroughs Wellcome Co., et al. Valaciclovir and acyclovir for the treatment of recurrent genital herpes simplex virus infections. Abstract #1211, Program of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, 17-20 October, 1993.
13. Sexually transmitted disease treatment guidelines. MMWR 1993;42(RR-14):1-102.
14. Douglas JM, Critchlow C, Benedetti J, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984;310:1551-1556.
15. Luby JP, Guann JW Jr., Alexander WJ, et al. A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo. J Infect Dis 1984;150:1-6.
16. Sacks SL, Aoki FY, Diaz-Mitoma F, et al. Patient-Initiated Treatment (tx) of Recurrent Genital Herpes (RGH) with Oral Famciclovir (FCV): A Canadian, Multicenter, Placebo (PLB)-Controlled, Dose-Ranging Study. Abstract #H4, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 4-7 October 1994.
17. Sacks SL, Portnoy J, Lawee D, et al. Clinical course of recurrent genital herpes after treatment with foscarnet cream; Results of a Canadian multicenter trial. J Infect Dis 1987;155:178-186.
18. Sacks SL, Varner TL, Davies KS, et al. Randomized, double-blind, placebo-controlled, patient-initiated study of topical high and low-dose interferon-alpha with nonoxynol-9 in the treatment of recurrent genital herpes. J Infect Dis 1990;161:692-698.
19. Lebwohl M, Sacks S, Conant M, et al. Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis. Antiviral Res 1992;17(3):235-43.
20. Sacks SL, Tyrrell LD, Lawee D, et al. Randomized, double-blind, placebo-controlled, clinic-initiated, Canadian multicenter trial of topical edoxudine 3% cream in the treatment of recurrent genital herpes. J Infect Dis 1991;164:665-672.
21. Wald A, Barnum G, Selke S, et al. Acyclovir suppresses asymptomatic shedding of HSV-2 in the genital tract. Abstract #H5, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 4-7 October 1994.
22. Mindel A, Faherty A, Carney O, et al. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988;1:926-8.
23. Goldberg LH, Kaufman R, Kurtz TO, et al. Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group. Arc Derm 1993;129:582-7.
24. Fife KH, Crumpacker CS, Mertz GJ, et al. Recurrence and resistance patterns of herpes simplex virus following cessation of 6 years of chronic acyclovir suppression. J Infect Dis 1994;169:1338-41.
25. Mertz GJ, Loveless MO, Kraus SJ, et al. Famciclovir for suppression of recurrent genital herpes. Abstract #H3, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 4-7 October 1994.
26. Kinghorn GR, Woolley PD, Thin RN, et al. Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection. Genitourinary Medicine 1992;68(5):312-6.
27. Wade JC, Newton B, Flournoy N, et al. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 1984;100:823-828.
28. Saral R, Ambinder RF, Burns WH, et al. Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1983;99:773-776.
29. Cooper DA, Pehrson O, Pederson C et al. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir in the treatment of patients with AIDS and AIDS-related complex: a double blind, randomized trial. AIDS 1993; 7: 197-207.
30. Youle MS, Gazzard BG, Johnson MA et al. Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. AIDS 1994; 8: 641-649.
31. Stein DS, Graham NMH, Park LP et al. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival: Analysis of data in the Multicenter AIDS Cohort Study. Ann Intern Med 1994; 121: 100-108.
32. Wade JC, Newton B, McClaren C, et al. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med 1982;96:265-269.
33. Shepp DH, Newton BA, Dandliker PS, et al. Oral acyclovir therapy for mucocutaneous herpes simplex virus infectious in immunocompromised marrow transplant recipients. Ann Intern Med 1985;102:783-785.